ResearcherChinese PLA General HospitalActive in the last 2 years

Yuanxin Yao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8797-4208; OpenAlex author ID A5139660936. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

L3MBTL4 methylation is a sensitive marker of DNA-PK inhibitor in pancreatic cancer. Co-author DOI 10.37349/etat.2026.1002382 ↗
Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer. Co-author DOI 10.1007/s11684-023-1053-3 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mingzhou Guo · 1 shared paper, 2026 · strength 0.30
- Paper L3MBTL4 methylation is a sensitive marker of DNA-PK inhibitor in pancreatic cancer. DOI 10.37349/etat.2026.1002382 ↗
Lirong Zhang · 1 shared paper, 2024 · strength 0.20
- Paper Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancre… DOI 10.1007/s11684-023-1053-3 ↗
Mingzhou Guo · 1 shared paper, 2024 · strength 0.20
- Paper Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancre… DOI 10.1007/s11684-023-1053-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.